Ignite Creation Date:
2025-12-25 @ 2:41 AM
Ignite Modification Date:
2026-01-07 @ 10:51 AM
Study NCT ID:
NCT02926833
Status:
COMPLETED
Last Update Posted:
2024-03-06
First Post:
2016-10-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Safety and Efficacy of KTE-C19 in Combination With Atezolizumab in Adults With Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Sponsor:
Kite, A Gilead Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-09-29
Start Date Type:
ACTUAL
Primary Completion Date:
2023-01-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-01-12
Completion Date Type:
ACTUAL
First Submit Date:
2016-10-05
First Submit QC Date:
None
Study First Post Date:
2016-10-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-06-08
Results First Submit QC Date:
None
Results First Post Date:
2020-06-26
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2019-12-11
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2024-02-13
Last Update Post Date:
2024-03-06
Last Update Post Date Type:
ACTUAL